|
US2020372989A1
|
|
Systems and methods for dispensing a statin medication over the counter
|
|
US2019381005A1
|
|
Methods for lowering blood sugar with a dipeptidyl peptidase-4 inhibitor pharmaceutical composition
|
|
CA3103617A1
|
|
Methods for lowering blood sugar with a metformin pharmaceutical composition
|
|
AU2019287541A1
|
|
Methods for treating and preventing symptoms of asthma with a corticosteroid pharmaceutical composition
|
|
AU2019287546A1
|
|
Methods for treating erectile dysfunction with a cGMP-specific phosphodiesterase 5 inhibitor pharmaceutical composition
|
|
CA3103616A1
|
|
Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition
|
|
AU2019287551A1
|
|
Methods for treatment of hypertension with an angiotensin II receptor blocker pharmaceutical composition
|
|
WO2019241588A1
|
|
Methods for treating erectile dysfunction with a cgmp-specific phosphodiesterase 5 inhibitor pharmaceutical composition
|
|
US2019385725A1
|
|
Methods for lowering blood sugar with a gliflozin sodium-glucose cotransport 2 inhibitor pharmaceutical composition
|
|
WO2019241563A1
|
|
Methods for lowering triglyceride levels with a concentrated fish oil-based pharmaceutical composition
|
|
US2018173855A1
|
|
Systems and methods for dispensing a statin medication over the counter
|
|
EP3029569A1
|
|
Systems for allowing annotation in real time
|
|
AU2015200276A1
|
|
A filled canister for an inhaler
|
|
GB201307568D0
|
|
Tablet dispensing device
|
|
GB201307572D0
|
|
Dispensing device
|
|
CN107252420A
|
|
The pharmaceutical composition of rosuvastatin calcium
|
|
GB201207330D0
|
|
Tablet dispensing device
|
|
GB201207335D0
|
|
Dispensing device
|
|
WO2013123996A1
|
|
Novel sirna inhibitors of human icam-1
|
|
WO2011098798A1
|
|
Process for providing a filled canister for an inhaler
|
